US 10611845
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
granted A61KA61K2039/505A61K47/65
Quick answer
US patent 10611845 (Activatable antibodies that bind interleukin-6 receptor and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/505, A61K47/65